Skip to Main Content

Author Details

Raphael E Pollock
James Cancer Center, The Ohio State University
1984
365
78
PMIDPaper TitleJournal TitlePublished Year
36369098Prognostic factors in patients receiving surgery and radiation therapy for retroperitoneal sarcoma: A machine-learning analysis.Surgery2023
37052491Small Non-Coding RNAs in Soft-Tissue Sarcomas: State of the Art and Future Directions.Mol Cancer Res2023
37237004Phosphorylation of IWS1 by AKT maintains liposarcoma tumor heterogeneity through preservation of cancer stem cell phenotypes and mesenchymal-epithelial plasticity.Oncogenesis2023
37433985Notch signaling regulates a metabolic switch through inhibiting PGC-1α and mitochondrial biogenesis in dedifferentiated liposarcoma.Oncogene2023
37330448Adjuvant Palbociclib May be Associated with Delayed Recurrence in Completely Resected Retroperitoneal Liposarcoma: Results of a Single-Institution Retrospective Cohort Study.Ann Surg Oncol2023
36847778Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma.Cancer Res2023
36905579Emerging Trends in Immunotherapy for Adult Sarcomas.Oncologist2023
36763259Three dimensional models of dedifferentiated liposarcoma cell lines: scaffold-based and scaffold-free approaches.Hum Cell2023
34586640Clinical biomarkers in soft tissue sarcoma A comprehensive review of current soft tissue sarcoma biomarkers.J Surg Oncol2022
35705558Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma.Nat Commun2022
35796636The Role of AKT in Soft Tissue Sarcoma: Review and Insights.Mol Cancer Res2022
35530299ATR inhibition sensitizes liposarcoma to doxorubicin by increasing DNA damage.Am J Cancer Res2022
35454972Cancer-Derived Extracellular Vesicles: Their Role in Sarcoma.Life (Basel)2022
36661688Morbidity and Mortality after Surgery for Retroperitoneal Sarcoma.Curr Oncol2022
36043432In situ hybridization to detect DNA amplification in extracellular vesicles.J Extracell Vesicles2022
36240209Preclinical efficacy of the Wnt/β-catenin pathway inhibitor BC2059 for the treatment of desmoid tumors.PLoS One2022
35045964Correction: SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma.Clin Cancer Res2022
35301612Correction: Morbidity and Outcomes After Distal Pancreatectomy for Primary Retroperitoneal Sarcoma: An Analysis by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group.Ann Surg Oncol2022
35326514Targetable Pathways in the Treatment of Retroperitoneal Liposarcoma.Cancers (Basel)2022
34338924Disease Biology is "King" in Retroperitoneal Liposarcoma.Ann Surg Oncol2021
33740198Morbidity and Outcomes After Distal Pancreatectomy for Primary Retroperitoneal Sarcoma: An Analysis by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group.Ann Surg Oncol2021
33650695Modern multimodality management of patients with caval leiomyosarcoma: New treatment paradigms and potential molecular insights.J Surg Oncol2021
33643547Cross-flow microfiltration for isolation, selective capture and release of liposarcoma extracellular vesicles.J Extracell Vesicles2021
34758653Resection Status Does Not Impact Recurrence in Well-Differentiated Liposarcoma of the Extremity.Am Surg2021
34691462Metastatic and locally aggressive BCC: Current treatment options.Clin Case Rep2021
32258243Cracking the riddle of dedifferentiated liposarcoma: is EV-MDM2 a key?Oncoscience2020
33519169Multi-Layer Micro-Nanofluidic Device for Isolation and Capture of Extracellular Vesicles Derived from Liposarcoma Cell Conditioned Media.J Microelectromech Syst2020
32030677Adipose Tumor Microenvironment.Adv Exp Med Biol2020
32048291A sommelier to guide wine selection and a specialist to manage the sarcoma patient: Barriers to referral and definition of a sarcoma specialist.J Surg Oncol2020
32651460β-catenin S45F mutation results in apoptotic resistance.Oncogene2020
32340193Enhancing Antitumor Efficacy of Heavily Vascularized Tumors by RAMBO Virus through Decreased Tumor Endothelial Cell Activation.Cancers (Basel)2020
32503455Activity of PD1 inhibitor therapy in advanced sarcoma: a single-center retrospective analysis.BMC Cancer2020
32470489Extracellular vesicle cross-talk in the liposarcoma microenvironment.Cancer Lett2020
32232871Neoadjuvant radiation improves margin-negative resection rates in extremity sarcoma but not survival.J Surg Oncol2020
32402509The sacral chordoma margin.Eur J Surg Oncol2020
31088817Synchronous recurrence of concurrent colon adenocarcinoma and dedifferentiated liposarcoma.BMJ Case Rep2019
31387924<i>MDM2</i> Derived from Dedifferentiated Liposarcoma Extracellular Vesicles Induces MMP2 Production from Preadipocytes.Cancer Res2019
31197851Targeted muscle reinnervation in oncologic amputees: Early experience of a novel institutional protocol.J Surg Oncol2019
31534435Corrigendum to "SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy".Sarcoma2019
31019022Degree of <i>MDM2</i> Amplification Affects Clinical Outcomes in Dedifferentiated Liposarcoma.Oncologist2019
30980399Autophagy inhibition overcomes sorafenib resistance in S45F-mutated desmoid tumors.Cancer2019
28885122Clinicopathological variables of sporadic schwannomas of peripheral nerve in 291 patients and expression of biologically relevant markers.J Neurosurg2018
30209066The TLR7/8/9 Antagonist IMO-8503 Inhibits Cancer-Induced Cachexia.Cancer Res2018
30092432A Case of Acute Iliocaval Thrombosis in the Setting of a Suprarenal Inferior Vena Cava Saccular Aneurysm.Ann Vasc Surg2018
29983640miR-133a function in the pathogenesis of dedifferentiated liposarcoma.Cancer Cell Int2018
30173530Surgical management of retroperitoneal sarcoma and opportunities for global collaboration.Chin Clin Oncol2018
30173525Multidisciplinary management of soft tissue sarcoma.Chin Clin Oncol2018
29848707Second Primary Malignancies in Patients with Well-differentiated/Dedifferentiated Liposarcoma.Anticancer Res2018
29871905Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival.Clin Cancer Res2018
30526918Multidisciplinary sarcoma care.Curr Probl Surg2018
  • 1 - 50 of 365

Recommended Authors

Siriraj Hospital, Mahidol University
Career Start Year 2017
Number of shared co-authors 3
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2015
Number of shared co-authors 0
Stanford Cancer Institute, Stanford School of Medicine
Career Start Year 2010
Number of shared co-authors 4
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 2009
Number of shared co-authors 3
Diagnostic and Research Institute of Pathology, Medical University of Graz
Career Start Year 2003
Number of shared co-authors 6
University College London, Cancer Institute
Career Start Year 2003
Number of shared co-authors 6
The Johns Hopkins Hospital
Career Start Year 2001
Number of shared co-authors 7
University of California los angeles
Career Start Year 2001
Number of shared co-authors 8
Samsung Medical Center, Sungkyunkwan University
Career Start Year 2001
Number of shared co-authors 0
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 2
Washington University School of Medicine and Siteman Cancer Center
Career Start Year 1999
Number of shared co-authors 3
Stanford University
Career Start Year 1996
Number of shared co-authors 2
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1994
Number of shared co-authors 3
Mount Sinai Hospital
Career Start Year 1994
Number of shared co-authors 10
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Servicio de Anatomia Patologica. Hospital Universitario Virgen del Rocio.
Career Start Year 1992
Number of shared co-authors 8
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 1992
Number of shared co-authors 8
University College London Hospitals NHS Foundation Trust
Career Start Year 1991
Number of shared co-authors 4
University of California-Los Angeles
Career Start Year 1990
Number of shared co-authors 6
Oregon Health & Science University
Career Start Year 1990
Number of shared co-authors 2
Dartmouth-Hitchcock Medical Center
Career Start Year 1990
Number of shared co-authors 2
University of Colorado School of Medicine
Career Start Year 1989
Number of shared co-authors 4
Mayo Clinic
Career Start Year 1989
Number of shared co-authors 8
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 0
GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp
Career Start Year 1988
Number of shared co-authors 8
Children's Hospital at Montefiore.
Career Start Year 1986
Number of shared co-authors 4
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 6
University Hospitals Birmingham NHS Foundation Trust
Career Start Year 1984
Number of shared co-authors 5
Duke School of Medicine
Career Start Year 1984
Number of shared co-authors 0
Osteosarcoma Institute
Career Start Year 1977
Number of shared co-authors 10

Collaborators

The University of Texas MD Anderson Cancer Center
Co-authored papers 73
The University of Texas MD Anderson Cancer Center
Co-authored papers 59
Co-authored papers 26
Sylvester Comprehensive Cancer Center, University of Miami
Co-authored papers 21
Co-authored papers 12
Mount Sinai Hospital and Laboratory Medicine and Pathobiology, University of Toronto
Co-authored papers 10
University of Texas MD Anderson Cancer Center
Co-authored papers 10
The University of Texas MD Anderson Cancer Center
Co-authored papers 9
MD Anderson Cancer Center
Co-authored papers 8
Tianjin Medical University Cancer Institute and Hospital
Co-authored papers 6
University of Miami Miller School of Medicine
Co-authored papers 6
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Co-authored papers 5
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Dartmouth-Hitchcock Medical Center
Co-authored papers 4
Brigham and Women's Hospital and Harvard Medical School
Co-authored papers 4
South China University of Technology
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Institute for Systems Biology
Co-authored papers 4
Co-authored papers 4
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 3
Children's Hospital, Zhejiang University School of Medicine
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Co-authored papers 3
Rutgers Cancer Institute of New Jersey
Co-authored papers 2
Brigham and Women's Hospital
Co-authored papers 2
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2